Comments
Drug firm Ajanta Pharma on Friday reported a 23 per cent rise in consolidated net profit to ₹159 crore for the quarter ended March 2021 on account of robust sales.
The company had posted a net profit of ₹129 crore for the corresponding period of the previous fiscal, Ajanta Pharma said in a regulatory filing.
Consolidated revenue from operations stood at ₹757 crore for the quarter under consideration. It was ₹682 crore in the year ago period, it added.
For the fiscal year ended March 2021, the net profit of the company was at ₹654 crore compared to ₹468 crore in the previous financial year, the filing said.
Revenue from operations came in at ₹2,890 crore for 2020-21. It was ₹2,588 crore for the previous financial year, it added.
Shares of Ajanta Pharma closed at ₹1,834 per scrip on BSE, down 2.97 per cent from its previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.